disopyramide has been researched along with phenytoin in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 56 (76.71) | 18.7374 |
1990's | 2 (2.74) | 18.2507 |
2000's | 9 (12.33) | 29.6817 |
2010's | 6 (8.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
Jolivette, LJ; Ward, KW | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Sen, S; Sinha, N | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Theisen, K | 1 |
Donaldson, RM | 1 |
Carson, IW; Lyons, SM; Shanks, RG | 1 |
Singh, BN | 1 |
Koch-Weser, J | 1 |
Aitio, ML | 1 |
Pennock, RS | 1 |
Anderson, JL; Harrison, DC; Meffin, PJ; Winkle, RA | 1 |
Mason, JW; Winkle, RA | 1 |
Farshidi, A; Greenspan, AM; Horowitz, LN; Josephson, ME; Michelson, EL; Spielman, SR | 1 |
Arnsdorf, MF; Mehlman, DJ | 1 |
Barrillon, A; Grand, A | 1 |
Loogen, F | 1 |
Araú, A; Bonhorst, D; Bordalo, A; De Azevedo, JG; Ferreira, M; Ferreira, R; Inês, L; Lacximy, I; Longo, A; Luis Martins, J; Melo, M; Nunes Diogo, A; Ribeiro, C; Sanches, C; Teixeira, J | 1 |
Kwieciński, H; Ostrzycki, A; Ryniewicz, B | 1 |
Ekblom, M; Hammarlund-Udenaes, M; Lundqvist, T; Sjöberg, P | 1 |
Podrid, PJ | 1 |
Keefe, DL; Miura, D; Somberg, JC | 1 |
Somberg, J | 1 |
Roden, DM; Siddoway, LA; Woosley, RL | 1 |
Andersson, KE; Wettrell, G | 1 |
Huang, SK; Marcus, FI | 1 |
Nappi, JM; Nightingale, J | 1 |
Barland, P; Epstein, A | 1 |
Fossati, C | 1 |
Hashimoto, K; Imai, S; Shibuya, T | 1 |
Hashimoto, S; Kanazawa, T; Miura, M; Ono, Y | 1 |
Hauswirth, O; Singh, BN | 1 |
Combre, A; Duchêne-Marullaz, P; Lapalus, P; Lavarenne, J | 1 |
Carlier, J; Lisin, N | 1 |
Reid, PR; Vlay, SC | 1 |
Elkayam, U; Frishman, W; Rotmensch, HH | 1 |
Ali, C; Holt, DW; Volans, GN | 1 |
Doherty, JU; Josephson, ME; Kienzle, MG; Williams, PD; Zygmont, D | 1 |
Jahrmärker, H; Theisen, K | 1 |
Halawa, B; Mazurek, W | 1 |
Garson, A; Gillette, PC | 1 |
Howanitz, JH; Howanitz, PJ | 1 |
Kerr, CR; Levick, CE; Mizgala, HF | 1 |
Rosen, MR; Wit, AL | 1 |
Block, PJ; Winkle, RA | 1 |
Haeckel, R; Haindl, H; Oellerich, M | 1 |
Bricaud, H; Lévy, RH; Lévy, S | 1 |
Cho, YW; Kuemmerle, HP; Singh, BN | 1 |
Hashimoto, K; Imai, S; Satoh, H; Shibuya, T | 2 |
Buxton, AE; Josephson, ME; Sadowski, LM; Waxman, HL | 1 |
Chiariello, M; Condorelli, M; Ferro, G; Tari, MG; Ungaro, B; Vigorito, C | 1 |
Arensberg, D; Felner, JM; Stanford, JL | 1 |
Carlier, J | 1 |
Dreifus, LS; Morganroth, J | 1 |
Moses, HW; Yu, PN | 1 |
Drake, CE | 1 |
Aitio, A; Aitio, ML; Haataja, M; Mansury, L; Tala, E | 1 |
Affrime, MB; Lowenthal, DT | 1 |
Herling, IM; Horowitz, LN; Josephson, ME | 1 |
Aitio, ML; Vuorenmaa, T | 1 |
Endou, H; Enomoto, A; Hasannejad, H; Huang, XL; Jung, SH; Narikawa, S; Niwa, T; Onozato, ML; Takeda, M; Taki, K; Tojo, A | 1 |
22 review(s) available for disopyramide and phenytoin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Anti-arrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Anesthetics; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Dogs; Humans; Intraoperative Complications; Lidocaine; Mexiletine; Phenytoin; Procainamide; Succinylcholine | 1979 |
Rational basis of antiarrhythmic therapy: clinical pharmacology of commonly used antiarrhythmic drugs.
Topics: Action Potentials; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Disopyramide; Heart; Humans; Lidocaine; Phenytoin; Procainamide; Propranolol; Quinidine; Sympatholytics; Time Factors | 1978 |
Prevention of sudden coronary death by chronic antiarrhythmic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Disopyramide; Drug Evaluation; Humans; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Time Factors; Ventricular Fibrillation | 1978 |
[Incompatibility and interference of the major cardiologic drugs. Their undesirable effects].
Topics: Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antihypertensive Agents; Bradycardia; Cardiac Glycosides; Digitalis Glycosides; Disopyramide; Drug Interactions; Drug Synergism; Humans; Hypertension; Hypokalemia; Isoproterenol; Lidocaine; Monoamine Oxidase Inhibitors; Ouabain; Phenytoin; Prenylamine; Procainamide; Quinidine | 1976 |
The role of antiarrhythmic drugs in prevention of sudden cardiac death.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Disopyramide; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Random Allocation; Tocainide | 1985 |
The treatment of ventricular rhythm disturbances.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disopyramide; Electric Countershock; Electric Stimulation; Electrocardiography; Exercise Test; Flecainide; Heart Ventricles; Humans; Lidocaine; Phenytoin; Piperidines; Procainamide; Quinidine; Risk; Tachycardia; Tocainide; United States; Ventricular Fibrillation; Verapamil | 1986 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Clinical pharmacology of old and new antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Biological Availability; Bretylium Compounds; Disopyramide; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Tocainide | 1985 |
Cardiovascular drugs. I: Antidysrhythmic drugs.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Cardiovascular Agents; Disopyramide; Drug Interactions; Humans; Kinetics; Lidocaine; Mexiletine; Phenytoin; Procainamide; Tocainide; Verapamil | 1986 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
[Pharmacologic problems with teratogenic drugs].
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Anesthetics; Anti-Arrhythmia Agents; Anticonvulsants; Disopyramide; Female; Humans; Phenytoin; Pregnancy; Propranolol; Quinidine; Solvents; Teratogens | 1985 |
[Treatment of extrasystole (ventricular and atrial extrasystoles)].
Topics: Adrenergic beta-Antagonists; Ajmaline; Aniline Compounds; Benzyl Compounds; Cardiac Complexes, Premature; Disopyramide; Hemodynamics; Humans; Imidazoles; Lidocaine; Phenytoin; Procainamide; Propanolamines; Propranolol; Quinidine | 1974 |
Comparative mechanisms of action of antiarrhythmic drugs.
Topics: Action Potentials; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Benzyl Compounds; Bretylium Compounds; Calcium; Carbamazepine; Chemical Phenomena; Chemistry; Diethylamines; Disopyramide; Heart; Humans; Imidazoles; Iodobenzoates; Lidocaine; Membrane Potentials; Phenyl Ethers; Phenytoin; Procainamide; Propylamines; Quinidine; Verapamil | 1974 |
Antiarrhythmic drug therapy during pregnancy.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Breast Feeding; Digitalis Glycosides; Disopyramide; Female; Fetus; Humans; Infant, Newborn; Lidocaine; Maternal-Fetal Exchange; Phenytoin; Pregnancy; Pregnancy Complications, Cardiovascular; Procainamide; Quinidine; Tachycardia; Verapamil | 1983 |
Antiarrhythmic drug therapy for sustained ventricular tachycardia.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bethanidine; Calcium Channel Blockers; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Encainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Phenytoin; Piperidines; Procainamide; Quinidine; Tachycardia; Tocainide | 1984 |
[Medical treatment of extrasystole and tachycardia (author's transl)].
Topics: Action Potentials; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium; Cardiac Complexes, Premature; Digoxin; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Verapamil | 1980 |
Antiarrhythmic drug monitoring.
Topics: Acecainide; Anti-Arrhythmia Agents; Disopyramide; Humans; Lidocaine; Phenytoin; Procainamide; Propranolol; Quinidine | 1981 |
Electropharmacology of antiarrhythmic drugs.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Electric Conductivity; Heart Atria; Heart Ventricles; Humans; Lidocaine; Membrane Potentials; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Procainamide; Propranolol; Purkinje Fibers; Quinidine; Tocainide; Verapamil | 1983 |
Hemodynamic effects of antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Bretylium Compounds; Calcium Channel Blockers; Disopyramide; Dose-Response Relationship, Drug; Encainide; Flecainide; Hemodynamics; Humans; Lidocaine; Mexiletine; Myocardial Contraction; Phenytoin; Piperidines; Procainamide; Quinidine; Tocainide | 1983 |
Antiarrhythmic agents and their use in therapy.
Topics: Acebutolol; Animals; Anti-Arrhythmia Agents; Digitalis Glycosides; Disopyramide; Humans; Lidocaine; Oxytocin; Phenytoin; Procainamide; Propranolol; Quinidine; Verapamil | 1980 |
Antiarrhythmic drugs.
Topics: Anti-Arrhythmia Agents; Bretylium Tosylate; Disopyramide; Humans; Lidocaine; Phenytoin; Procainamide; Propranolol; Quinidine | 1980 |
3 trial(s) available for disopyramide and phenytoin
Article | Year |
---|---|
Prevention of sudden coronary death by chronic antiarrhythmic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Disopyramide; Drug Evaluation; Humans; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Time Factors; Ventricular Fibrillation | 1978 |
Treatment of myotonia with antiarrhythmic drugs.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Disopyramide; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Humans; Male; Mexiletine; Middle Aged; Myotonia; Myotonia Congenita; Myotonic Dystrophy; Neurologic Examination; Phenytoin; Prospective Studies; Single-Blind Method; Tocainide | 1992 |
The role of antiarrhythmic drugs in prevention of sudden cardiac death.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Disopyramide; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Random Allocation; Tocainide | 1985 |
50 other study(ies) available for disopyramide and phenytoin
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Molecular characteristics for solid-state limited solubility.
Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
[Drug therapy of tachyarrhythmias (author's transl)].
Topics: Action Potentials; Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Calcium; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Tachycardia; Verapamil | 1978 |
The treatment of supraventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Digoxin; Disopyramide; Electric Countershock; Humans; Phenytoin; Procainamide; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Verapamil | 1979 |
Disopyramide.
Topics: Disopyramide; Enzyme Induction; Humans; Phenytoin; Pyridines | 1979 |
How useful are serum levels of cardiac drugs?
Topics: Anti-Arrhythmia Agents; Digitalis Glycosides; Disopyramide; Heart Diseases; Humans; Lidocaine; Phenytoin; Procainamide; Propranolol; Quinidine | 1978 |
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Topics: Acebutolol; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds; Digitalis Glycosides; Disopyramide; Humans; Kinetics; Lidocaine; Mexiletine; Oxytocin; Phenytoin; Procainamide; Propranolol; Quinidine; Verapamil | 1978 |
Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Drug Evaluation; Electric Countershock; Electrocardiography; Female; Follow-Up Studies; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged; Monitoring, Physiologic; Phenytoin; Procainamide; Propranolol; Quinidine; Recurrence; Tachycardia | 1978 |
Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Drug Evaluation; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Follow-Up Studies; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged; Phenytoin; Procainamide; Quinidine; Recurrence; Tachycardia | 1978 |
Treatment of cardiac arrhythmias. Part II--The drugs.
Topics: Arrhythmias, Cardiac; Bretylium Compounds; Digitalis Glycosides; Disopyramide; Electric Countershock; Humans; Lidocaine; Pacemaker, Artificial; Phenytoin; Procainamide; Propranolol; Quinidine | 1978 |
Observations on the effects of selected antiarrhythmic drugs on mammalian cardiac purkinje fibers with two levels of steady-state potential: influences of lidocaine, phenytoin, propranolol, disopyramide and procainamide on repolarization, action potential
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Disopyramide; Heart Conduction System; In Vitro Techniques; Lidocaine; Membrane Potentials; Phenytoin; Procainamide; Propranolol; Purkinje Fibers; Sheep; Time Factors | 1978 |
[Sino-atrial conduction time].
Topics: Ajmaline; Disopyramide; Heart Conduction System; Humans; Phenytoin; Quinidine; Time Factors; Verapamil | 1977 |
Mechanism of action of antidysrhythmic drugs on ventricular conduction as studied with intramural electrodes.
Topics: Ajmaline; Animals; Disopyramide; Dogs; Electrocardiography; Heart Conduction System; Hydroxyzine; Lidocaine; Oxprenolol; Phenytoin; Propranolol; Purkinje Fibers; Quinidine; Verapamil | 1975 |
Potential use of microdialysis in pharmacokinetics: a protein binding study.
Topics: Aminoglutethimide; Dialysis; Disopyramide; Furosemide; Humans; Pharmacokinetics; Phenytoin; Protein Binding; Stereoisomerism | 1992 |
Effect of phenytoin on serum disopyramide concentrations.
Topics: Disopyramide; Drug Interactions; Humans; Kinetics; Male; Middle Aged; Phenytoin | 1987 |
The diagnostic value of antihistone antibodies in drug-induced lupus erythematosus.
Topics: Adolescent; Adult; Aged; Antibodies, Antinuclear; Autoantibodies; Child; Disopyramide; Female; Fluorescent Antibody Technique; Histones; Humans; Hydralazine; Lupus Erythematosus, Systemic; Male; Middle Aged; Penicillamine; Phenytoin; Procainamide | 1985 |
Cardiovascular and respiratory effects of antiarrhythmic drugs on conscious beagles.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Disopyramide; Dogs; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Lidocaine; Male; Phenytoin; Procainamide; Respiration; Verapamil | 1985 |
[Comparison of the effects of quinidine, diphenylhydantoin and disopyramide on the auricular refractory period in the anesthetized dog].
Topics: Animals; Atrial Function; Disopyramide; Dogs; Electric Stimulation; Female; Heart Atria; Heart Block; Male; Neural Conduction; Phenytoin; Pyridines; Quinidine; Refractory Period, Electrophysiological | 1974 |
[Toxic and hemodynamic effects of aprindine in the dog. Comparison with other anti-arrhythmia agents].
Topics: Ajmaline; Aniline Compounds; Animals; Anti-Arrhythmia Agents; Aorta; Blood Pressure; Cardiac Output; Diethylamines; Disopyramide; Dogs; Heart Rate; Heart Ventricles; Hemodynamics; Indans; Indenes; Injections, Intravenous; Phenytoin; Procainamide; Pulmonary Artery; Quinidine; Respiration; Vascular Resistance | 1974 |
Ventricular ectopy: etiology, evaluation, and therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Echocardiography; Electric Stimulation; Humans; Ischemia; Lidocaine; Myocardial Infarction; Nitrates; Pacemaker, Artificial; Phenytoin; Procainamide; Radionuclide Imaging; Risk | 1982 |
Management of cardiac drug overdose.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Disopyramide; Humans; Phenytoin; Poison Control Centers; Verapamil | 1984 |
[Effect of various anti-arrhythmia drugs on serum digoxin level].
Topics: Aged; Anti-Arrhythmia Agents; Biological Availability; Cardiac Complexes, Premature; Digoxin; Disopyramide; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Phenytoin; Procainamide; Quinidine | 1981 |
Treatment of chronic ventricular dysrhythmias in the young.
Topics: Administration, Oral; Adolescent; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Child, Preschool; Chronic Disease; Disopyramide; Follow-Up Studies; Heart Ventricles; Hemodynamics; Humans; Infant; Infant, Newborn; Injections, Intravenous; Male; Phenytoin; Propranolol; Quinidine; Tachycardia | 1981 |
Failure to pace following high dose antiarrhythmic therapy--reversal with isoproterenol.
Topics: Amiodarone; Anti-Arrhythmia Agents; Disopyramide; Drug Therapy, Combination; Electrocardiography; Humans; Isoproterenol; Pacemaker, Artificial; Phenytoin; Procainamide; Tachycardia | 1984 |
Evaluation of EMIT adapted to the (Cobas) Bio centrifugal analyzer.
Topics: Centrifugation; Digoxin; Disopyramide; Humans; Immunoenzyme Techniques; Methotrexate; Phenytoin; Radioimmunoassay; Thyroxine | 1982 |
[Pharmacokinetics of anti-arrhythmics. 2. Clinical applications].
Topics: Administration, Oral; Anti-Arrhythmia Agents; Disopyramide; Humans; Kinetics; Lidocaine; Perfusion; Phenytoin; Procainamide; Propranolol; Quinidine | 1980 |
Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Humans; Kinetics; Lidocaine; Mexiletine; Phenytoin; Procainamide; Propranolol; Tocainide | 1981 |
Quantitative analysis of the antiarrhythmic effect of drugs on canine ventricular arrhythmias by the determination of minimum effective plasma concentrations.
Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Dogs; Female; Lidocaine; Male; Mexiletine; Phenytoin; Verapamil | 1983 |
The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Female; Heart Ventricles; Humans; Lidocaine; Male; Middle Aged; Phenytoin; Procainamide; Quinidine; Tachycardia | 1983 |
Intropic effects of several antiarrhythmic drugs.
Topics: Ajmaline; Anti-Arrhythmia Agents; Aprindine; Blood Pressure; Bunaftine; Coronary Disease; Disopyramide; Heart Rate; Hemodynamics; Humans; Lidocaine; Mexiletine; Middle Aged; Myocardial Contraction; Phenytoin; Procainamide | 1983 |
Antiarrhythmic drug therapy.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digitalis Glycosides; Disopyramide; Heart Conduction System; Humans; Lidocaine; Phenytoin; Procainamide; Quinidine | 1980 |
Hemodynamic, electrocardiographic and toxic effects of the intravenous administration of increasing doses of mexiletine in the dog. Comparison with similar effects produced by other antiarrhythmics.
Topics: Ajmaline; Animals; Anti-Arrhythmia Agents; Aprindine; Disopyramide; Dogs; Electrocardiography; Hemodynamics; Injections, Intravenous; Mexiletine; Myocardial Contraction; Phenytoin; Procainamide; Propylamines | 1980 |
Cardiac drug overdose.
Topics: Arrhythmias, Cardiac; Bretylium Compounds; Cardiovascular Agents; Cardiovascular Diseases; Digoxin; Disopyramide; Humans; Hypotension; Lidocaine; Liver; Phenytoin; Procainamide; Propranolol; Quinidine; Vasodilator Agents | 1982 |
Canine-effective plasma concentrations of antiarrhythmic drugs on the two-stage coronary ligation arrhythmia.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Disopyramide; Dogs; Dose-Response Relationship, Drug; Isoquinolines; Lidocaine; Ligation; Phenytoin; Propanolamines; Verapamil | 1982 |
The effect of enzyme induction on the metabolism of disopyramide in man.
Topics: Adult; Disopyramide; Enzyme Induction; Female; Humans; Male; Middle Aged; Phenytoin; Pyridines; Rifampin; Time Factors | 1981 |
Cardiovascular drugs for the geriatric patient.
Topics: Aged; Aging; Antihypertensive Agents; Cardiovascular Agents; Cardiovascular Physiological Phenomena; Digoxin; Disopyramide; Humans; Intestinal Absorption; Kidney; Lidocaine; Phenytoin; Procainamide; Propranolol; Quinidine | 1981 |
Ventricular ectopic activity after medical and surgical treatment for recurrent sustained ventricular tachycardia.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Female; Heart Aneurysm; Heart Ventricles; Humans; Male; Middle Aged; Phenytoin; Postoperative Complications; Procainamide; Propranolol; Recurrence; Tachycardia | 1980 |
Enhanced metabolism and diminished efficacy of disopyramide by enzyme induction?
Topics: Aged; Creatine; Disopyramide; Drug Interactions; Enzyme Induction; Female; Humans; Inactivation, Metabolic; Male; Middle Aged; Phenytoin; Pyridines | 1980 |
Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs.
Topics: Animals; Anti-Arrhythmia Agents; Biological Transport; Cell Line; Disopyramide; Dose-Response Relationship, Drug; Histamine; Humans; Lidocaine; Mice; Organic Cation Transport Proteins; Phenytoin; Procainamide; Quinidine | 2004 |